ALIVUS LIFE SCIENCES
Back to Cashflow Statement
|
ALIVUS LIFE SCIENCES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-6.23 Cr | ₹-279 Cr | ₹-388 Cr | ₹-79 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALIVUS LIFE SCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-64 Cr |
| Mar2025 | ₹-6.23 Cr |
| Mar2024 | ₹-279 Cr |
| Mar2023 | ₹-388 Cr |
| Mar2022 | ₹-79 Cr |
How is Cash Flow from Financing Activities of ALIVUS LIFE SCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-64 Cr | Negative | |
| Mar2025 | ₹-6.23 Cr | Negative | |
| Mar2024 | ₹-279 Cr | Negative | |
| Mar2023 | ₹-388 Cr | Negative | |
| Mar2022 | ₹-79 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹17,640.0 Cr | -1% | 13.2% | 53.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -1% |
13.2% |
53.2% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses